维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Bessard"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocareinoma cells显示文摘	Bessard A Fremin C Ezan F	2007	J Cell Physiol2007，212，2：	1
2	HER - 2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma : a multi - center study of the GINECO Group 显示文摘	Camilleri Broet S Hardy -Bessard AC Le Toumeau A	2004	Ann Oncol2004，15，1：	1
3	Cetuximab, topotecan and cisplatin for the treatmentof 80 advanced cervical cancer: A phase H GINECOtrial 显示文摘	KURTZ J E HARDY - BESSARD A C DESLANDRESM	2009	Gynecol Oncol2009，113，1：	1
4	Isoprostanes as a biomarker of liPid peroxidation in humans : physiology, Phar - macology and clinical implication 显示文摘	Cracowski JL Durand T Bessard G	2002	Trends pharmacol Sci2002，23，8：	1
5	Isoprostanes as a biomarker of lipid peroxidation in humans:physiology,pharmacology and clinical implications显示文摘	Cracowski JL Durand T Bessard G	2002	Trends Pharmacol Sci2002，23，8：	1
6	Isoprostanes as a biomarker of lipid peroxidation in humans:physiology,pharmacology and clinical implications显示文摘	Cracowski JL Durand T Bessard G	2002	Trends Pharmacol Sci2002，23，8：	1
7	Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats显示文摘	Caron F Bessard G	2006	J Hypertens2006，24，：	1
8	Les antagonists desleukotrienes:une approach nonvelle du treatment de I'asthme显示文摘	Devilive PH Bessard G Advancer CH	1997	Revdes Maladies Respiratoirs1997，14，2：	1
9	Les antagonists des leukotrienes: une approach nonvelle du treatment de l'asthme 显示文摘	Devilive PH Bessard G Advancer CH	1997	Revdes Maladies Respiratoirs1997，14，2：	1
10	MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells显示文摘	Bessard A Fremin C Ezan F		0，，2：	1
11	Les antagonists des leucotrienes: une approache nouvelle du treatment de 1' asthma 显示文摘	Devillier PH Bessard G Advancer CH	1997	Rev Malad Respir1997，14，：	1
12	RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo显示文摘	Gailhouste L Ezan F Bessard A	2010	Int J Cancer2010，126，6：	1
13	HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multi- center study of the GINECO group显示文摘	Camilleri Broet S Hardy Bessard A C Le Toumeau A	2004	Ann Oncol2004，15，1：	1
14	Angiotensin Ⅱ -induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition 显示文摘	Stanke-Labesque F Devillier P Bedouch P Cracowski JL Chavanon O Bessard G	2000	Cardiovasc Res2000，47，2：	1
15	GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells 显示文摘	Andrieux LO Fautrel A Bessard A	2007	Cancer Res2007，67，5：	1
16	GATA- 1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells 显示文摘	ANDRIEUX L O FANTREL A BESSARD A	2007	Cancer Res2007，67，5：	1
17	显示文摘	Corompt E Bessard G Lantuejoul S	1998	Naunyn Schmiedebergs Arch Pharmacol1998，357，：	1
18	Les antagonists des leukotrienes:une approach nonvelle du treatment de I' asthme显示文摘	Devilive PH Bessard G Advancer CH	1997	Revdes Maladies Respiratoirs1997，14，2：	1
19	MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinomaa cell显示文摘	Bessard A Fremin C Ezan F	2007	J Cell Physiol2007，212，2：	1
20	Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications显示文摘	Jean-Luc Cracowski Thierry Durand Germain Bessard	2002	Trends in Pharmacological Sciences2002，，8：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示